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Abstract 
Objective. Asthma is a common clinical 
complication of pregnancy and women with asthma 
are at greater risk of having complications. This 
study compared adverse maternal outcomes 
between women with asthma and women without 
asthma in Nevada. 
Methods. A total of 64,664 hospital discharges of 
delivery were abstracted from the Nevada 
2003-2004 hospital discharges and thirteen adverse 
maternal outcomes were examined. Logistic 
regression was applied to compare the maternal 
outcomes between women with and without 
asthma.  
Results. Women with asthma were more likely to 
have pre-eclampsia (OR [CI] 1.73 [1.13, 2.65]), 
transient hypertension of pregnancy (OR [CI] 1.76 
[1.11, 2.78]), pregnancy-induced hypertension (OR 
[CI] 1.89 [1.42, 2.53]), gestational diabetes (OR 
[CI] 1.89 [1.32, 2.72]), infection of the amniotic 
cavity (OR [CI] 2.15 [1.29, 3.58]), and cesarean 
section (OR [CI] 1.87 [1.56, 2.23] ).  
Conclusion. Women with asthma experienced a 
greater risk of having adverse maternal outcomes. 
Community-based education programs, as well as, 
services offered in traditional healthcare settings 
should be supported to educate pregnant women 
about the potential risk factors and the relationship 
between asthma and maternal outcomes.  
Key Words: asthma, adverse maternal outcome, 
pregnant women, Nevada  
 
Introduction 
  Asthma, a common chronic disease, has 
become more prevalent in recent years (Bhatnagar 
& Givelber 1999). The self-reported prevalence 
rate increased from 3.1% (6.8 million) to 5.6% 
(14.9 million) in the general population from the 
early 2000’s to the mid-2000’s (Moorman, et al 
2007). The National Health Interview Survey Data 
for lifetime and current asthma (NHIS Data 2006) 
report that asthma prevalence percent is 7.8% (22.9 
million) in 2006 in the United States (Center for 
Disease Control 2009). According to findings of a 
large prospective cohort study conducted in the 
northeastern United States, the prevalence rate of 
asthma was 8.4% among the pregnant population 
making it one of the most common clinical 
complications of pregnancy (Kwon, Triche, 
Belanger, & Bracken 2006). Uncontrolled asthma 
events during pregnancy is related to a high risk of 
certain adverse outcomes, such as intrauterine 
growth restriction (Mabie, Barton,Wasserstrum, & 
Sabai 1992), preeclampsia (Triche, Saftlas, 
Belanger, Leader, & Bracken 2004), hypertensive 
disorder of pregnancy, membrane-related disorders, 
preterm labor, antepartum hemorrhage, and 
cesarean delivery (Enriquez, et al 2007), as well as, 
adverse infant outcomes (Karimi, Davar, Mirzaei, 
& Mirzaei 2008).  
   Whereas most of these referenced 
studies are relatively limited in sample size, studies 
based on large sample size also have indicated 
associations between asthma and adverse maternal 
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outcomes, such as premature delivery, low 
birth-weight, fetal death, pregnancy induced 
hypertension, hyperbilirubinemia, and an increased 
rate of operative delivery (MacMullen, Tymkow, & 
Shen 2006; Wen, DeMissie, & Liu 2001). These 
associations persist even when coexisting clinical 
conditions are taken into account (Sheiner, Mazor, 
Levy, Wiznitzer, & Bashiri 2005). Finally, a 
meta-analysis concludes that uncontrolled asthma 
increases the risk of low birth weight, preterm 
delivery, and complications in pregnancies 
(Murphy, Gibson, Smith, & Clifton 2005). 
  Given the limited number of comparison 
studies focusing on asthma and adverse maternal 
outcomes in other parts of the nation, along with 
the lack of literature that compares adverse 
maternal outcomes of pregnant versus 
non-pregnant women in Nevada, our literature 
review suggests that this study would contribute to 
a body of evidence which focuses on risk reduction 
for pregnant women with asthma in the state. 
   The purpose of this study was to 
examine whether adverse maternal outcomes 
between women with asthma and women without 
asthma were different in Nevada, and to determine 
whether these findings were consistent with results 
at the national level. Since asthma is a respiratory 
disease with symptoms of airway obstruction, 
airway inflammation and increased airway 
responsiveness to a variety of stimuli, and smoking 
is a trigger of an asthma attack (NAEPP 2007), 
from a health policy standpoint, implementation of 
the Nevada Clean Indoor Air Act (NCIAA) may 
have potential benefits of reducing the risk of 
smoke-triggered asthma, and in turn, improve 
maternal outcomes in the state.   
Methods 
  Data were abstracted from the Nevada 2003 
and 2004 State Inpatient Data (SID), available 
through the Health Care Cost and Utilization 
Project (HCUP), which is sponsored by the Agency 
for Healthcare Research and Quality (AHRQ). A 
total of 64,664 pregnant women aged 13 or older 
who delivered in 2003 and 2004 were selected 
based on International Classification of Diseases, 
Ninth Edition, Clinical Modification (ICD-9-CM) 
Diagnostic Codes. Among the entire delivery cases, 
661 discharges with asthma were identified by 
ICD-9-CM diagnostic code of 463. The 2004 
American Hospital Association (AHA) annual 
survey data was merged with the SID data by the 
use of the AHA identification number to provide 
hospital variables. 
   Based on the literature (Liu, et al 2001; 
MacMullen, Tymkow, & Shen 2006; Shen, 
Tymkow, & MacMullun 2005), a total of thirteen 
adverse maternal outcome measures, being used as 
dependent variables, were investigated in this study. 
They included preterm labor, hypertensive 
disorders of pregnancy (consisting of three 
measures:, pre-eclampsia, transient hypertension of 
pregnancy, and pregnancy-induced hypertension), 
gestational diabetes, antepartum hemorrhage 
(including two measures:, placenta previa and 
abruptio placenta), membrane disorders (including 
two measures:, premature rupture of membranes 
and infection of the amniotic cavity), cesarean 
section, prolonged labor, postpartum hemorrhage, 
and fetal death. Each dependant variable was coded 
as a dummy variable with the value ―1‖ indicating 
an adverse outcome event, and the value ―0‖ as a 
nonevent.  
   The primary independent variable was 
asthma, with the value ―1‖ representing the 
pregnant woman with asthma as a comorbidity, and 
the value ―0‖ representing the pregnant woman 
without asthma.  
   Multiple logistic regression was used to 
examine the relationship between the asthma 
comorbidity during pregnancy, and each of the 
thirteen adverse maternal outcome measures, 
respectively. The odds ratio (OR) was derived to 
approximate the risk ratio that indicated the risk of 
the adverse outcome anticipated among women 
with asthma over women without asthma. 
-Covariates such as patient demographics, health 
insurance status, comorbidities, and hospital 
characteristics were controlled in the multivariable 
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analysis. To make the age variable more 
meaningful, we defined seven dummy variables to 
represent seven age groups (younger than 15 years 
old, 15-19, 20-24, 25-29, 30-34, 35-39, and equal 
or older than 40 years), and the age group 25-29 
was utilized as the reference group. The patient’s 
residence was categorized as: large metropolitan 
areas with at least one million residents, small 
metropolitan areas with less than one million 
residents, micropolitan areas, and non-urban areas. 
Hospital characteristics, such as size (i.e., large, 
medium, and small with small hospitals being the 
reference) and teaching hospital status were 
controlled. In addition, patient’s insurance status 
was categorized as Medicare, Medicaid, private 
insurance, uninsured and other insurance with 
private insurance being the reference group. The 
goodness-of-fit for the multivariable model for all 
of the thirteen dependent variables, except for 
infection of the amniotic cavity and prolonged 
labor, was greater than 0.05, which indicated good 
model fit for most of the variables 
(Hosmer&Lemeshow 2000).  
Results 
   About 1.03% of pregnant women, who 
delivered in a hospital environment, had asthma in 
Nevada in 2003 and 2004. Table 1 shows the 
unadjusted descriptive results for the thirteen 
adverse maternal outcomes and patients’ 
socio-demographics. The average ages at delivery 
for women with and without asthma were similar. 
The asthma group had a higher percentage of 
women who resided in large urban areas, however, 
it had lower rate for women who delivered in 
teaching hospitals. The average length of stay for 
women with asthma was 3.0 days and for women 
without asthma, it was 2.2 days (p < 0.01). Total 
hospital charges for women with asthma were on 
average $4,000 higher than the charges for women 
without asthma (p < 0.01). Women with asthma 
experienced higher risk for all the thirteen adverse 
outcomes except prolonged labor and fetal death. 
Results of the bivariate analysis indicated that 
asthma was a statistically significant risk factor 
related to six of the thirteen adverse outcome 
measures.  
   Table 2 shows the adjusted adverse 
maternal outcomes for women with asthma as 
compared with women without asthma. Women 
with asthma were more likely to have 
pre-eclampsia (OR [CI] 1.73 [1.13, 2.65]), transient 
hypertension of pregnancy (OR [CI] 1.76 [1.11, 
2.78]), pregnancy-induced hypertension (OR [CI] 
1.89 [1.42, 2.53]), gestational diabetes (OR [CI] 
1.89 [1.32, 2.72]), infection of the amniotic cavity 
(OR [CI] 2.15 [1.29, 3.58]), cesarean section (OR 
[CI] 1.87 [1.56, 2.23] ), and uterine tumor (OR [CI] 
2.75 [1.42, 5.30]). 
Discussion 
   In Nevada, women with asthma 
experienced a greater risk of having adverse 
pregnancy outcomes than did women without 
asthma, after controlling for insurance status, 
maternal age, comorbidities, rural residence, and 
hospital characteristics. Pregnant women with 
asthma experienced more pre-eclampsia, transient 
hypertension of pregnancy, pregnancy-induced 
hypertension, gestational diabetes, infection of the 
amniotic cavity, cesarean section, and uterine tumor. 
These findings were consistent with findings of 
prior studies in other parts of the country (Mabie, et 
al 1992; Sheiner, et al 2005; Triche, et al 2004), 
including a study based on a national representative 
sample (MacMullen, et al 2006), and the national 
guidelines of asthma diagnosis and treatment 
(NAEPP 2007).  
  More care is needed for women with asthma 
during the delivery process due to related 
complications. Asthma is associated with longer 
hospital stay and consequently hospital charges for 
the delivery process for women with asthma are 
higher than women without asthma.  
  Limitations inherent in the use of 
administrative data existed in this study. It was 
unknown whether the circumstances of women 
with asthma were under control or not. Infant 
outcomes were not available in the SID dataset, 
either. In addition, the data we used in were almost 
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six years old, trends of asthma and related 
complications can change during this period. 
Finally, information about patient severity of 
asthma, regular outpatient care, medication use, 
and emergency room visits was unavailable. 
Nevertheless, the availability of diagnostic 
information was one of the strengths of this study 
as compared to those based on self-reported asthma. 
Further, our findings provide a basic understanding 
of the relationship between asthma and adverse 
maternal outcomes in Nevada. Future research may 
compare the effects of controlled versus 
non-controlled asthma on maternal outcomes, 
examine the relationship between hospitals’ quality 
of care and maternal outcomes for women with 
asthma, or study the effects of patients’ factors on 
maternal outcomes for women with asthma among 
Nevada residents.  
     Policy implications: Both public and  
private sectors should support asthma related 
education programs available within community 
and healthcare settings. Such programs will educate 
pregnant women and their families about the 
association between asthma and maternal outcomes, 
and the methods to assess the potential risk factors 
such as smoking, respiratory infections, and other 
asthma triggers that may lead to a severe attack. 
Patient education should include the avoidance of 
risk factors and asthma self-management skills. 
Finally, hospitals and other healthcare providers 
should follow existing guidelines (NAEPP, 2007) 
to manage the potential risk for pre-eclampsia, 
transient hypertension of pregnancy, 
pregnancy-induced hypertension, gestational 
diabetes, infection of the amniotic cavity, and the 
possibility of cesarean birth for women with 
asthma during their pregnancy.   









(n = 64664) p-value 
Social demographics       
  Average age, year (St.d) 27.0 (6.1) 27.1 (6.4) 27.0 (6.1)  
  Age group     
     < 15 128(0.2) 1(0.2) 129(0.2)  
     15 - 19 7075(11.0) 82(12.4) 7157(11.1)  
     20 - 24 17042(26.6) 179(27.1) 17221(26.6)  
     25 - 29 17707(27.7) 152(23.0) 17859(27.6)  
     30 - 34 13955(21.8) 155(23.5) 14110(21.8)  
     35 - 39 6647(10.4) 74(11.2) 6721(10.4)  
     >= 40 1449(2.3) 18(2.7) 1467(2.3)  
  Area of residence     
     Large metropolitan >= 1 million 
residents  46952(73.4) 532(80.5) 47484(73.4)  
     Small metropolitan < 1 million 
residents 11900(18.6) 53(8.0) 11953(18.5)  
     Micropolitan areas 2973(4.7) 50(7.6) 3023(4.7)  
     Non-urban 2017(3.2) 26(3.9) 2043(3.2)  
Comorbidities     
  Obesity 410(0.6) 30(4.5) 440(0.7)  
  Depression 224(0.4) 15(2.3) 239(0.4)  
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Maternal outcomes (Table 1, con’t)     
  Pre-term labor 1906(3.0)  24(3.6) 1930(3.0) 0.33 
  Hypertensive disorders of pregnancy     
     Pre-eclampsia 1517(2.4) 26(3.9) 1543(2.4) <0.01 
     Transient hypertension of pregnancy 1245(2.0) 26(3.9) 1271(2.0) <0.01 
     Pregnancy-induced hypertension 3141(4.9) 67(10.1) 3208(5.0) <0.01 
  Gestational diabetes 1976(3.1) 40(6.1) 2016(3.1) <0.01 
  Antepartum hemorrhage     
     Placenta previa 295(0.5) 6(0.9) 301(0.5) 0.09 
     Abruptio placenta 819(1.3) 11(1.7) 830(1.3) 0.38 
  Membrane disorders     
     Premature rupture of membrane 2066(3.2) 22(3.3) 2088(3.2) 0.88 
     Infection of the amniotic cavity 1005(1.6) 20(3.0) 1025(1.6) <0.01 
  Mode of Delivery     
     Cesarean section 18571(29.0) 310(46.9) 18881(29.2) <0.01 
  Others     
     Prolonged labor 5344(8.4) 48(7.3) 5392(8.3) 0.31 
     Postpartum hemorrhage 1358(2.1) 17(2.6) 1375(2.1) 0.42 
     Uterine Tumor 404(0.6) 13(2.0) 417(0.6) <0.01 
     Fetal death 257(0.4) 2(0.3) 259(0.4) 0.69 
Hospitalization     
  Average length of stay, day (St.d.) 2.2(2.0) 3.0(3.5) 2.2(2.0) <0.01 
  Average total charges, $ (St.d) 8487(7296) 12115(13254) 8524(7390) <0.01 
  Median total charges, $  6938 9502 6959  
Insurance     
  Medicare 778(1.2) 8(1.2) 786(1.2)  
  Medicaid 19417(30.4) 198(30.1) 19615(30.4)  
  Private 36094(56.5) 414(62.9) 36508(56.6)  
  Uninsured 4665(7.3) 26(4.0) 4691(7.3)  
  Others 2893(4.5) 12(1.8) 2905(4.5)  
Hospital Characteristics     
  Teaching hospital 28560(44.7) 194(29.4) 28754(44.6)  
  Ownership     
     Public 12231(19.2) 89(13.5) 12320(19.1)  
     Non for profit  21466(33.6) 196(29.7) 21662(33.6)  
     Profit 30180(47.3) 376(56.9) 30556(47.4)  
  Size     
     Small hospital 19289(30.2) 246(37.2) 19535(30.3)  
     Medium hospital 5655(8.9) 76(11.5) 5731(8.9)  
     Large hospital 38933(61.0) 339(51.3) 39272(60.9)   
St.d. - standard deviation     
* Data are expressed as number and percentage unless otherwise indicated.  
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Table 2. Relationships between Asthma and Adverse Maternal Outcomes of Women  








  Pre-term labor† 1.00 1.29(0.80, 2.12) 0.30 0.59 
  Hypertensive disorders of pregnancy      
     Pre-eclampsia‡ 1.00 1.73(1.13, 2.65) 0.73 0.61 
     Transient hypertension of 
pregnancy‡ 1.00 1.76(1.11, 2.78) 0.59 0.63 
     Pregnancy-induced hypertension‡ 1.00 1.89(1.42, 2.53) 0.62 0.59 
  Gestational diabetes§ 1.00 1.89(1.32, 2.72) 0.74 0.70 
  Antepartum hemorrhage      
     Placenta previa 1.00 1.79(0.83, 3.84) 0.84 0.67 
     Abruptio placenta‡ 1.00 1.22(0.63, 2.35) 0.64 0.59 
  Membrane disorders      
     Premature rupture of membrane‡ 1.00 1.04(0.64, 1.69) 0.20 0.58 
     Infection of the amniotic cavity‡ 1.00 2.15(1.29, 3.58) 0.00 0.65 
  Mode of Delivery      
     Cesarean section¶ 1.00 1.87(1.56, 2.23) 0.55 0.66 
  Others      
     Prolong labor 1.00 0.99(0.71, 1.38) 0.01 0.63 
     Postpartum hemorrhage║ 1.00 1.34(0.81, 2.21) 0.23 0.61 
     Uterine Tumor 1.00 2.75(1.42, 5.30) 0.64 0.81 
     Fetal death 1.00 0.69(0.17, 2.80) 0.21 0.64 
† adjusted for maternal age.     
‡ adjusted for maternal age, gestational diabetes, pre-existing diabetes, and pre-existing hypertension.  
§ adjusted for maternal age, gestational diabetes, and pre-existing hypertension.  
¶ Risk Ratio, adjusted for ‡, plus pregnancy-induced hypertension, preterm labor, placenta previa, abrupture 
placenta, premature, rupture of membrane, and infection of the amniotic cavity.  
║adjusted for maternal age, coagulation disorders, uterine tumor, and cesarean section.  
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